Bombay, India

Goukanapalli C Reddy


Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1988-1992

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Goukanapalli C Reddy

Introduction

Goukanapalli C Reddy is a notable inventor based in Bombay, India. He has made significant contributions to the field of microbiology and pharmaceuticals. With a total of 3 patents to his name, Reddy's work focuses on the development of new antibiotics and their applications in medicine.

Latest Patents

Reddy's latest patents include groundbreaking innovations such as "Antibiotic, aranorosin, a microbiological process for the preparation thereof, and the use thereof as a pharmaceutical." This invention details a new antibiotic, aranorosin, which can be prepared using the fungus culture Y-30499 (DSM 4151). Aranorosin exhibits antibiotic properties and has shown effectiveness against malignant tumors. Another significant patent is related to the "macrolide antibiotic swalpamycin," which involves a microbiological process for its preparation and the use of a new microorganism strain, Streptomyces species. This antibiotic is intended for treating infections caused by bacteria, mycoplasmas, and Actinomycetes.

Career Highlights

Goukanapalli C Reddy is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical sector. His work at Hoechst has allowed him to focus on innovative solutions in antibiotic development and microbiological processes.

Collaborations

Reddy has collaborated with notable coworkers such as Bimal N Ganguli and Hans-Wolfram Fehlhaber. Their combined expertise has contributed to the advancement of Reddy's research and inventions.

Conclusion

Goukanapalli C Reddy's contributions to the field of microbiology and pharmaceuticals are noteworthy. His innovative patents in antibiotic development highlight his commitment to advancing medical science. Reddy's work continues to impact the treatment of infections and malignant tumors, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…